This web site is part of the Business Intelligence Division of Informa PLC
This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.
Drug Names(s): ZYT1
Description: ZYT1 is a New Molecular Entity (NME) anti-dyslipidemic agent that acts as a thyroid homone receptor beta (TR-beta) agonist and mayprovide an alternative to statins or be an add-on to statin therapy.
Additional information available to subscribers only: